Professor Faiez Zannad
Henri Poincaré University, Nancy, France
Faiez Zannad MD, PhD, is Professor of Therapeutics at the Medical Faculty of the Henri Poincaré University of Nancy, France. He obtained his MD as a cardiology specialist in 1979 from the Faculté de Médecine de Nancy. In 1981 he served as a research fellow at the Clinical Pharmacology Medical Research Council Unit of Oxford University, UK and in 1986 he obtained his PhD in cardiovascular clinical pharmacology at the University of Lyon, France.
He is currently Head of the Division of Heart Failure, Hypertension and Preventive Cardiology/ Department of Cardiovascular Disease at the academic hospital of Nancy, and Director of the Inserm Clinical Investigation Center (CIC). He is coordinator of a joint research programme on transition from hypertension to heart failure, in the EU funded Network of Excellence “InGeniousHyperCare”.
His research interests include physiopathology and pharmacotherapeutics of hypertension and heart failure.
Dr Zannad is Chairman of the board of the French Society of Hypertension, Fellow of the European Society of Cardiology (ESC), Member of the borad of the ESC Heart Failure Association, Vice-chairman of the ESC working group on pharmacology and drug therapy and a member of multiple international societies in cardiology, hypertension, pharmacology and therapeutics. He is currently Co-Editor in Chief of Fundamental and Clinical Pharmacology and sits on the editorial boards of a number of cardiology, hypertension and cardiovascular pharmacology journals. He has contributed to more than 300 scientific publications and published several books on cardiovascular pharmacotherapy and on heart failure.
In addition, Dr Zannad is highly involved in a number of major ongoing cardiovascular clinical trials.